Has Keith Lawhorn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,639,137 in general payments to Keith Lawhorn, MD across 567 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Keith Lawhorn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Keith Lawhorn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Keith Lawhorn, MD

Orthopaedic Surgery · Fairfax, VANPI 1083614218

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,194,718 of the $1,639,137 with a category attached, or 72.9%. Zimmer Biomet accounts for 99.9% of it on its own, with 10 other manufacturers making up the rest. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,639,137in general payments, 2019–2025

Across 567 payments — averaging $2890.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$1.6M
Aesculap Biologics, LLC$731
Medacta USA, Inc.$233
Vericel Corporation$204
Supreme Orthopedic Systems, LLC$131
Smith+Nephew$56
plus $124 from 5 others

$125,001in research payments, 2019–2025

Across 34 payments — averaging $3676.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$123K
Aesculap Biologics, LLC$2K

What the payments were for

Royalty or licence$1,194,71873%
Consulting fees$398,77224%
Travel & lodging$38,3812%
Food & beverage$7,2460%
Education$190%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	540	$1,637,659
Aesculap Biologics, LLC	5	$731
Medacta USA, Inc.	2	$233
Vericel Corporation	12	$204
Supreme Orthopedic Systems, LLC	1	$131
Smith+Nephew	2	$56
Johnson & Johnson	1	$53
Bioventus LLC	1	$27
Stryker	1	$17
Pacira Pharmaceuticals Incorporated	1	$16
Arteriocyte Medical Systems, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,639,137 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$249,039

Medicare patients

483

Services billed

21,959

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methylprednisolone	13	$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fairfax

Bradley BoydFairfax$540K
Christopher SilveriFairfax$184K
Robert HymesFairfax$78K
Dale YoungNorth Chesterfield$10.9M
James DowdVirginia Beach$6.1M
Mark de BloisNorth Chesterfield$4M
Cato LaurencinCharlottesville$3.5M
Randall PeytonSterling$2.9M
William MihalkoCharlottesville$2M
David MillerNorth Chesterfield$1.7M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →